Background A Task Force was convened by the EFNS/MDS‐ES Scientist Panel on P
arkinson's disease (PD) and other movement disorders to systemically review relevant …

The differential diagnosis of parkinsonian syndromes is considered one of the most
challenging in neurology and error rates in the clinical diagnosis can be high even at …

ABSTRACT PSP is a pathologically defined neurodegenerative tauopathy with a variety of
clinical presentations including typical Richardson's syndrome and other variant PSP …

Conventional magnetic resonance imaging (cMRI) is often used to aid the diagnosis of
progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), but its ability to …

Frontotemporal dementia encompasses a group of clinical syndromes defined
pathologically by degeneration of the frontal and temporal lobes. Historically, these …

To date, the most frequently used Parkinson's disease (PD) biomarkers are the brain
imaging measures of dopaminergic dysfunction using positron emission tomography and …

Objectives: MRI-based measurements used to diagnose progressive supranuclear palsy
(PSP) typically lack pathologic verification and are not easy to use routinely. We aimed to …

Historically, magnetic resonance imaging (MRI) has contributed little to the study of
Parkinson's disease (PD), but modern MRI approaches have unveiled several …

The differential diagnosis of parkinsonian syndromes is considered one of the most
challenging in neurology, even for movement disorder specialists. Despite published …

Background: Several morphometric magnetic resonance imaging parameters may serve for
differential diagnosis of parkinsonism. The objective of this study was to identify which …